Privia Health Group (PRVA) Competitors $21.33 +0.18 (+0.85%) Closing price 04:00 PM EasternExtended Trading$21.33 0.00 (0.00%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRVA vs. GH, OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, VCYT, and ADUSShould you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Veracyte (VCYT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. Privia Health Group vs. Its Competitors Guardant Health Option Care Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Veracyte Addus HomeCare Privia Health Group (NASDAQ:PRVA) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Do insiders and institutionals have more ownership in PRVA or GH? 94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 10.7% of Privia Health Group shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts recommend PRVA or GH? Privia Health Group currently has a consensus target price of $28.00, indicating a potential upside of 31.27%. Guardant Health has a consensus target price of $57.50, indicating a potential downside of 6.17%. Given Privia Health Group's higher probable upside, research analysts plainly believe Privia Health Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Privia Health Group 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.92Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06 Is PRVA or GH more profitable? Privia Health Group has a net margin of 0.78% compared to Guardant Health's net margin of -49.93%. Privia Health Group's return on equity of 2.13% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Privia Health Group0.78% 2.13% 1.25% Guardant Health -49.93%N/A -28.95% Which has better earnings & valuation, PRVA or GH? Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrivia Health Group$1.74B1.51$14.39M$0.11193.91Guardant Health$739.02M10.34-$436.37M-$3.35-18.29 Which has more volatility and risk, PRVA or GH? Privia Health Group has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Does the media favor PRVA or GH? In the previous week, Guardant Health had 4 more articles in the media than Privia Health Group. MarketBeat recorded 9 mentions for Guardant Health and 5 mentions for Privia Health Group. Guardant Health's average media sentiment score of 1.17 beat Privia Health Group's score of 1.08 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPrivia Health Group beats Guardant Health on 10 of the 16 factors compared between the two stocks. Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRVA vs. The Competition Export to ExcelMetricPrivia Health GroupMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.62B$2.08B$5.74B$9.56BDividend YieldN/AN/A4.53%4.08%P/E Ratio193.9337.4330.4525.16Price / Sales1.519.69392.5887.64Price / Cash117.5550.4237.0358.50Price / Book3.576.498.956.21Net Income$14.39M-$63.67M$3.26B$265.38M7 Day Performance2.99%0.87%1.06%-1.13%1 Month Performance5.80%0.32%4.31%-0.71%1 Year Performance9.78%21.57%28.40%18.89% Privia Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRVAPrivia Health Group4.2024 of 5 stars$21.33+0.9%$28.00+31.3%+6.8%$2.62B$1.74B193.931,140News CoveragePositive NewsAnalyst UpgradeGHGuardant Health3.0924 of 5 stars$54.80+1.1%$57.50+4.9%+111.3%$6.76B$739.02M-16.362,021Positive NewsOPCHOption Care Health4.6502 of 5 stars$27.85-1.2%$35.75+28.4%-12.3%$4.58B$5.00B22.288,088News CoveragePositive NewsRDNTRadNet3.2895 of 5 stars$62.00+16.2%$69.60+12.3%+10.3%$4.00B$1.83B-144.1811,021Positive NewsAnalyst UpgradeHigh Trading VolumeSHCSotera Health1.2365 of 5 stars$14.06+0.6%$16.00+13.8%+9.4%$3.97B$1.10B175.773,000High Trading VolumeBTSGBrightSpring Health Services1.6615 of 5 stars$20.66-0.6%$25.67+24.2%+92.9%$3.68B$11.27B66.6535,000Positive NewsSGRYSurgery Partners2.9356 of 5 stars$22.74-3.8%$33.00+45.1%-14.4%$3.03B$3.11B-15.9015,000WGSGeneDx2.3527 of 5 stars$110.54+5.1%$101.63-8.1%+250.9%$3.02B$305.45M2,210.801,200CONConcentra Group Holdings Parent2.3728 of 5 stars$21.47-0.7%$28.50+32.7%-0.5%$2.77B$1.90B18.0411,250News CoveragePositive NewsVCYTVeracyte2.8089 of 5 stars$27.99+2.3%$40.90+46.1%-6.9%$2.15B$445.76M84.82790ADUSAddus HomeCare4.7788 of 5 stars$111.95+1.6%$142.86+27.6%-11.9%$2.03B$1.15B24.7149,703Positive NewsAnalyst Forecast Related Companies and Tools Related Companies GH Competitors OPCH Competitors RDNT Competitors SHC Competitors BTSG Competitors SGRY Competitors WGS Competitors CON Competitors VCYT Competitors ADUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRVA) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access